feed,title,long_url,short_url
SeekingAlpha,Intellia Therapeutics gets FDA greenlight for NTLA-5001 leukemia study,https://seekingalpha.com/news/3740366,
SeekingAlpha,Salsarita’s selects PAR Technology’s cloud-based solutions,https://seekingalpha.com/news/3740365,
SeekingAlpha,Phio Pharma jumps 18% after mPH-3861 showed durable and systemic anti-tumor immune response,https://seekingalpha.com/news/3740364,
